24 10-ヒドロキシ-ジヒドロシンコニジン誘導体の立体選択的合成
スポンサーリンク
概要
- 論文の詳細を見る
Stereoselective synthesis of the metabolites (2 and 3) of 7'-trifluoromethyl dihydrocinchonidine (1), antiarrhythmic agent, has been achieved as described below. The key synthon (14) of guinuclidine moiety of 2 (C_<10>-R) was synthesized starting from loganin (4). Reductive amination of the aglycone of 4 followed by the successive treatments of 5 with 3N HCl, NaBH_3CN, and PhCOCl gave 8. The Baeyer-Villiger oxidation of 10, Jones' oxidation product of 8, afforded the lactone (12), which was transformed to 14 in 3 steps. Another synthon (30) was synthesized from 1S-(3-pyridyl)ethanol (15). Hydroboration of the key intermediate, E-olefine (27) prepared from 15 in 7 steps, gave the C_<10>-S lactone (28), which was converted to the synthon (30). Condensation of 30 with 7-trifluoromethyllepidine (32) afforded the ketone (34). Then 34 was converted to the olefine (40) via 37 and 38. Reduction of 40 with DIBAH followed by refluxing the resulting amine (42) in 10% H_2O-MeOH gave the cyclized product (44a,b). Finally, stereospecific hydroxylation at C-9 of 44a,b with oxygen and desilylation of (45a dnd 45b) gave 10S-metabolite 3 and the isomer 50. In a similar manner, 10R-metabolite (2) was also synthesized from 14 and 32.
- 1982-09-10
著者
-
新間 信夫
日本ロシュ(株)研究所
-
新間 信夫
日本ロッシュ研究所
-
Kompis I.
米国ホフマン・ラ・ロッシュ
-
Gruenman V.
米国ホフマン・ラ・ロッシュ
-
Uskokovic M.
米国ホフマン・ラ・ロッシュ
関連論文
- 67 新規コレシストキニンタイプB受容体阻害物質Ro 09-1468の構造(ポスター発表の部)
- 新規抗癌剤カペシタビンの研究開発
- 25 新規ホスホリパーゼC阻害物質Ro 09-1450の構造(ポスター発表の部)
- 40 新規フォスフォリパーゼC阻害物質Hispidospermidinの構造決定(口頭発表の部)
- 24 10-ヒドロキシ-ジヒドロシンコニジン誘導体の立体選択的合成